The estimated Net Worth of William A Lee is at least $18.6 millió dollars as of 23 April 2007. William Lee owns over 31,741 units of Gilead Sciences stock worth over $4,726,815 and over the last 21 years William sold GILD stock worth over $13,894,702.
William has made over 22 trades of the Gilead Sciences stock since 2003, according to the Form 4 filled with the SEC. Most recently William sold 31,741 units of GILD stock worth $2,632,281 on 23 April 2007.
The largest trade William's ever made was exercising 92,796 units of Gilead Sciences stock on 23 April 2007 worth over $985,494. On average, William trades about 26,587 units every 43 days since 2003. As of 23 April 2007 William still owns at least 58,399 units of Gilead Sciences stock.
You can see the complete history of William Lee stock trades at the bottom of the page.
William's mailing address filed with the SEC is , , , , .
Over the last 21 years, insiders at Gilead Sciences have traded over $221,090,692 worth of Gilead Sciences stock and bought 30,121 units worth $1,879,767 . The most active insiders traders include John C Martin, Norbert W Bischofberger és John F Milligan. On average, Gilead Sciences executives and independent directors trade stock every 9 days with the average trade being worth of $3,341,365. The most recent stock trade was executed by Deborah H Telman on 10 September 2024, trading 639 units of GILD stock currently worth $51,721.
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
Gilead Sciences executives and other stock owners filed with the SEC include: